Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Clinical trial NCT03646123 · TERMINATED

Trial details

NCT number: NCT03646123
Sponsor: Seagen Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Lymphoma

Start date: 2019-01-28
Primary completion: 2022-11-07
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.